Cargando…
Co-targeting of delta-like ligand 4 (DLL4) and vascular endothelial growth factor a (VEGF) with programmed death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649383/ http://dx.doi.org/10.1186/2051-1426-3-S2-P373 |
| _version_ | 1782401346541977600 |
|---|---|
| author | Srivastava, Minu Murriel, Christopher Yun, Rui Mayes, Erin Jie, Hyun-Bae Axelrod, Fumiko Xie, Ming-Hong Bentley, Trevor Cancilla, Belinda Tam, Raymond O'Young, Gilbert Kapoun, Ann Lewicki, John Hoey, Tim Gurney, Austin Inkyung, Park Angie |
| author_facet | Srivastava, Minu Murriel, Christopher Yun, Rui Mayes, Erin Jie, Hyun-Bae Axelrod, Fumiko Xie, Ming-Hong Bentley, Trevor Cancilla, Belinda Tam, Raymond O'Young, Gilbert Kapoun, Ann Lewicki, John Hoey, Tim Gurney, Austin Inkyung, Park Angie |
| author_sort | Srivastava, Minu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4649383 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46493832015-11-24 Co-targeting of delta-like ligand 4 (DLL4) and vascular endothelial growth factor a (VEGF) with programmed death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses Srivastava, Minu Murriel, Christopher Yun, Rui Mayes, Erin Jie, Hyun-Bae Axelrod, Fumiko Xie, Ming-Hong Bentley, Trevor Cancilla, Belinda Tam, Raymond O'Young, Gilbert Kapoun, Ann Lewicki, John Hoey, Tim Gurney, Austin Inkyung, Park Angie J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649383/ http://dx.doi.org/10.1186/2051-1426-3-S2-P373 Text en Copyright © 2015 Srivastava et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Srivastava, Minu Murriel, Christopher Yun, Rui Mayes, Erin Jie, Hyun-Bae Axelrod, Fumiko Xie, Ming-Hong Bentley, Trevor Cancilla, Belinda Tam, Raymond O'Young, Gilbert Kapoun, Ann Lewicki, John Hoey, Tim Gurney, Austin Inkyung, Park Angie Co-targeting of delta-like ligand 4 (DLL4) and vascular endothelial growth factor a (VEGF) with programmed death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses |
| title | Co-targeting of delta-like ligand 4 (DLL4) and vascular endothelial growth factor a (VEGF) with programmed death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses |
| title_full | Co-targeting of delta-like ligand 4 (DLL4) and vascular endothelial growth factor a (VEGF) with programmed death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses |
| title_fullStr | Co-targeting of delta-like ligand 4 (DLL4) and vascular endothelial growth factor a (VEGF) with programmed death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses |
| title_full_unstemmed | Co-targeting of delta-like ligand 4 (DLL4) and vascular endothelial growth factor a (VEGF) with programmed death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses |
| title_short | Co-targeting of delta-like ligand 4 (DLL4) and vascular endothelial growth factor a (VEGF) with programmed death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses |
| title_sort | co-targeting of delta-like ligand 4 (dll4) and vascular endothelial growth factor a (vegf) with programmed death 1 (pd1) blockade inhibits tumor growth and facilitates anti-tumor immune responses |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649383/ http://dx.doi.org/10.1186/2051-1426-3-S2-P373 |
| work_keys_str_mv | AT srivastavaminu cotargetingofdeltalikeligand4dll4andvascularendothelialgrowthfactoravegfwithprogrammeddeath1pd1blockadeinhibitstumorgrowthandfacilitatesantitumorimmuneresponses AT murrielchristopher cotargetingofdeltalikeligand4dll4andvascularendothelialgrowthfactoravegfwithprogrammeddeath1pd1blockadeinhibitstumorgrowthandfacilitatesantitumorimmuneresponses AT yunrui cotargetingofdeltalikeligand4dll4andvascularendothelialgrowthfactoravegfwithprogrammeddeath1pd1blockadeinhibitstumorgrowthandfacilitatesantitumorimmuneresponses AT mayeserin cotargetingofdeltalikeligand4dll4andvascularendothelialgrowthfactoravegfwithprogrammeddeath1pd1blockadeinhibitstumorgrowthandfacilitatesantitumorimmuneresponses AT jiehyunbae cotargetingofdeltalikeligand4dll4andvascularendothelialgrowthfactoravegfwithprogrammeddeath1pd1blockadeinhibitstumorgrowthandfacilitatesantitumorimmuneresponses AT axelrodfumiko cotargetingofdeltalikeligand4dll4andvascularendothelialgrowthfactoravegfwithprogrammeddeath1pd1blockadeinhibitstumorgrowthandfacilitatesantitumorimmuneresponses AT xieminghong cotargetingofdeltalikeligand4dll4andvascularendothelialgrowthfactoravegfwithprogrammeddeath1pd1blockadeinhibitstumorgrowthandfacilitatesantitumorimmuneresponses AT bentleytrevor cotargetingofdeltalikeligand4dll4andvascularendothelialgrowthfactoravegfwithprogrammeddeath1pd1blockadeinhibitstumorgrowthandfacilitatesantitumorimmuneresponses AT cancillabelinda cotargetingofdeltalikeligand4dll4andvascularendothelialgrowthfactoravegfwithprogrammeddeath1pd1blockadeinhibitstumorgrowthandfacilitatesantitumorimmuneresponses AT tamraymond cotargetingofdeltalikeligand4dll4andvascularendothelialgrowthfactoravegfwithprogrammeddeath1pd1blockadeinhibitstumorgrowthandfacilitatesantitumorimmuneresponses AT oyounggilbert cotargetingofdeltalikeligand4dll4andvascularendothelialgrowthfactoravegfwithprogrammeddeath1pd1blockadeinhibitstumorgrowthandfacilitatesantitumorimmuneresponses AT kapounann cotargetingofdeltalikeligand4dll4andvascularendothelialgrowthfactoravegfwithprogrammeddeath1pd1blockadeinhibitstumorgrowthandfacilitatesantitumorimmuneresponses AT lewickijohn cotargetingofdeltalikeligand4dll4andvascularendothelialgrowthfactoravegfwithprogrammeddeath1pd1blockadeinhibitstumorgrowthandfacilitatesantitumorimmuneresponses AT hoeytim cotargetingofdeltalikeligand4dll4andvascularendothelialgrowthfactoravegfwithprogrammeddeath1pd1blockadeinhibitstumorgrowthandfacilitatesantitumorimmuneresponses AT gurneyaustin cotargetingofdeltalikeligand4dll4andvascularendothelialgrowthfactoravegfwithprogrammeddeath1pd1blockadeinhibitstumorgrowthandfacilitatesantitumorimmuneresponses AT inkyungparkangie cotargetingofdeltalikeligand4dll4andvascularendothelialgrowthfactoravegfwithprogrammeddeath1pd1blockadeinhibitstumorgrowthandfacilitatesantitumorimmuneresponses |